Health Canada releases updated warnings about Elmiron related vision loss
Health Canada released a Dear Health Professional Letter on December 15, 2020 to advise healthcare professionals, including urologists, urogynecologists, ophthalmologists, optometrists, family physicians, and pharmacists about cases of pigmentary maculopathy reported with use of Elmiron. As …
View the post titled Health Canada releases updated warnings about Elmiron related vision lossHow to trim eDiscovery costs part four: Set your review team up for success
In my previous blog posts How to trim eDiscovery costs part one: Laying the groundwork, How to trim eDiscovery costs part two: Review fewer documents and review efficiently, and How to trim eDiscovery costs part three: Leverage technology by adding tools and apps to your review, I discussed …
View the post titled How to trim eDiscovery costs part four: Set your review team up for successHow to trim eDiscovery costs part three: Leverage technology by adding tools and apps to your review
In my previous blog posts How to trim eDiscovery costs part one: Laying the groundwork, and How to trim eDiscovery costs part two: Review fewer documents and review efficiently, I discussed reducing eDiscovery costs by taking the time to set the stage before documents are exchanged, and by l…
View the post titled How to trim eDiscovery costs part three: Leverage technology by adding tools and apps to your reviewBritish Columbia Supreme Court rejects plan of arrangement for barring claims of historical shareholders
Overview In Re iAnthus Capital Holdings, Inc., 2020 BCSC 1442, Justice Gomery of the BCSC rejected a plan of arrangement due to the overly broad scope of release and injunction clauses which were found to bar claims of historical shareholders which preceded the plan. His Honour did not dismi…
View the post titled British Columbia Supreme Court rejects plan of arrangement for barring claims of historical shareholdersCourts reject “improvident” settlement in CHL class actions
Recent settlement approval decisions issued by the Ontario, Alberta and Quebec courts provide useful commentary on the appropriate scope of a release in a class action settlement. Class actions were commenced in Ontario, Alberta and Quebec concerning the employment status of major junior hoc…
View the post titled Courts reject “improvident” settlement in CHL class actionsHow many questions is too many on an examination for discovery by written interrogatories?
In a case of sufficient size and complexity, asking several hundred questions on an examination for discovery by written interrogatories may not be disproportionate absent bad faith or illegality, according to a recent decision of the Ontario Superior Court of Justice. In the recent case of …
View the post titled How many questions is too many on an examination for discovery by written interrogatories?How to trim eDiscovery costs part two: Review fewer documents and review efficiently
In my previous blog post How to trim eDiscovery costs part one: Laying the groundwork, I discussed reducing eDiscovery costs by taking the time to set the stage before documents are exchanged. In the next few weeks I will share some more of our practical tips in a series of short articles. H…
View the post titled How to trim eDiscovery costs part two: Review fewer documents and review efficientlyWhat is an honorarium, and is a representative plaintiff always entitled to a reward?
What is a representative plaintiff? In a class action, a representative plaintiff is a person who willingly steps forward and brings an action, in their name, on behalf of a class of similarly situated individuals. They play an active role in the litigation and assume important duties and re…
View the post titled What is an honorarium, and is a representative plaintiff always entitled to a reward?
Bladder pain medication Elmiron linked to vision loss
Elmiron, a drug to treat a bladder condition affecting hundreds of thousands of Canadians, has been reported to cause vision loss in long-term users. Elmiron is an oral medication approved to treat interstitial cystitis (also known as painful bladder syndrome). Scientific studies link long-t…
View the post titled Bladder pain medication Elmiron linked to vision lossThe Securities and Exchange Commission amends its whistleblower program
On September 23, 2020, the US Securities and Exchange Commission (“SEC”) finalized changes to its highly successful whistleblower program (the “SEC Program”)1. Since it began, the SEC Program has paid over $500 million in total rewards to tipsters. Earlier this June, one anonymous individu…
View the post titled The Securities and Exchange Commission amends its whistleblower programReceive Blog Posts
By subscribing to our blog, you will receive an email when a new post is added. You can unsubscribe at any time by sending an email to us at [email protected] with the word “unsubscribe” in the subject line.